Christopher Newman on Muck Rack

Christopher Newman

Washington
As seen in: BMJ Open, MDPI, The BMJ, NewsBreak, Healthcare Dive, BioPharma Dive, Manufacturing Dive
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Christopher

Contact Christopher, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Newman, Christopher: Amazon.co.uk: Kindle Store

|
By Christopher Newman
| geni.us
DISCOVER A MILLION-COPY BESTSELLING, EDGAR-NOMINATED CRIME THRILLER SERIES FROM CHRISTOPHER NEWMAN.Joe Dante is in the thick of it. After five brutal years undercover, infiltrating New York City’s most violent gangs, his cover is blown. Now he needs a fresh start. He’s transferred to the Tenth Precinct, and his reputation as a renegade lands him a case and a partner no one else wants. Alongside by-the-book Rosa Losada, he follows a trail of dead girls as they hunt for a sadistic serial killer.
Open in Who Shared Issue with article?

Physicians’ Self-Perceived Competence on Breaking Bad News to Parents of Children with Neurodisabilities

|
By Christopher Newman, Christopher John, Ophélie Fiorellino
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared Issue with article?

Medicare has no surprises in planned registry for new Alzheimer’s drugs

|
By Ben Fidler , Christopher Newman
| BioPharma Dive
Dive Brief: Medicare on Thursday gave more details on how it plans to cover new Alzheimer’s drugs once they receive full U.S. approval, emphasizing that a required patient registry will be free and easy to use. The additional guidance comes nearly a month after the Centers for Medicare and Medicaid Services affirmed its coverage policy on drugs like Eisai and Biogen’s Leqembi. The registry for tracking how the medicines work in the real world received pushback as an unnecessary hurdle to coverage.
Open in Who Shared Issue with article?
See all 149 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Christopher

Contact Christopher, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified